Almac

Life & health sciences

Trade

View all Case Studies

Northern Ireland company Almac Diagnostic Services offers bespoke precision medicine solutions to pharmaceutical and biotech companies worldwide.

Almac Diagnostic Services support global pharma and biotech companies with their precision medicine strategies from biomarker discovery through to companion diagnostic partnerships. With clinical and research laboratories in Europe and the USA, alongside strategic partnerships in China, Almac is enabling the support of global studies in Genomic Services, Clinical Trial Assays and Companion Diagnostics.

The company also provides proprietary biomarker discovery software solutions that global biopharma clients can access to support novel analysis of their DNA and RNA data such as claraT – A unique software reporting solution for cancer researchers looking at gene expression data.

The claraT report is a unique software-driven solution, classifying biologically relevant gene expression signatures into a comprehensive report, using the Hallmarks of Cancer for easy interpretation – saving oncology researchers’ valuable time, whilst maximising the understanding of their dataset.

Planned Growth

Invest NI is working closely with Almac as it invests in future growth plans, including supporting the company with investment in R&D to aid the development of proprietary gene expression assays and biomarker discovery & testing solutions. The company routinely exports to global markets primarily in the USA, Europe and China and has future ambitions to also target the Japanese market.

Invest NI has a network of overseas offices with advisors working closely with companies located in the region interested in developing strategic trading partnerships and relationships with Northern Ireland’s life and health sciences companies.

I believe we are entering a new era of personalised cancer care and the types of assays that are being developed by Almac, we believe will improve the overall outcome for cancer patients now and in the future.

Professor Paul Harkin, President and Managing Director, Almac Diagnostics

Northern Ireland Life & Health Sciences Sector

The region is at the forefront of medical innovation, specialising in the areas of Data Analytics & AI, Diagnostics, Digital Health, Precision Medicine, Clinical Trials and Medical devices. Employing 18,000 Northern Ireland’s vibrant cluster of 250+ companies are providing world-class solutions, exporting globally to over 140 countries thanks to a unique combination of talented people, world-class research and strong links between industry, academia and clinicians.

To find Life and Health Sciences companies view Northern Ireland’s company database:
https://www.investni.com/life-and-health-sciences-company-directory